Works matching AU Cheng-Yuan Peng
Results: 104
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1221, doi. 10.7326/M21-4119
- By:
- Publication type:
- Article
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 437, doi. 10.1111/ajco.12467
- By:
- Publication type:
- Article
Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 5, p. 2465, doi. 10.62347/DAGB7277
- By:
- Publication type:
- Article
Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 4, p. 1914, doi. 10.62347/EQIR8735
- By:
- Publication type:
- Article
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 785, doi. 10.1111/jvh.13715
- By:
- Publication type:
- Article
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 6, p. 568, doi. 10.1111/jvh.13265
- By:
- Publication type:
- Article
Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study.
- Published in:
- Gastroenterology Research & Practice, 2019, p. 1, doi. 10.1155/2019/1743290
- By:
- Publication type:
- Article
Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1347268
- By:
- Publication type:
- Article
Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 12, p. 1, doi. 10.1093/ofid/ofae699
- By:
- Publication type:
- Article
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac348
- By:
- Publication type:
- Article
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
- By:
- Publication type:
- Article
An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C.
- Published in:
- Hepatitis Monthly, 2015, v. 15, n. 3, p. 1, doi. 10.5812/hepatmon.27148
- By:
- Publication type:
- Article
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
- Published in:
- Journal of Infectious Diseases, 2020, v. 221, n. 4, p. 589, doi. 10.1093/infdis/jiz496
- By:
- Publication type:
- Article
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0160450
- By:
- Publication type:
- Article
Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140554
- By:
- Publication type:
- Article
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137852
- By:
- Publication type:
- Article
Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122259
- By:
- Publication type:
- Article
Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy.
- Published in:
- JGH Open, 2021, v. 5, n. 8, p. 929, doi. 10.1002/jgh3.12613
- By:
- Publication type:
- Article
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.
- Published in:
- Hepatology Research, 2016, v. 46, n. 7, p. 642, doi. 10.1111/hepr.12600
- By:
- Publication type:
- Article
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2022, p. 1, doi. 10.1155/2022/5201443
- By:
- Publication type:
- Article
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03006-3
- By:
- Publication type:
- Article
Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00621
- By:
- Publication type:
- Article
Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 8, p. 796, doi. 10.3390/v12080796
- By:
- Publication type:
- Article
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
- Published in:
- Journal of Biomedical Science, 2006, v. 13, n. 1, p. 27, doi. 10.1007/s11373-005-9030-1
- By:
- Publication type:
- Article
Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0244293
- By:
- Publication type:
- Article
The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese.
- Published in:
- BMC Immunology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2172-14-21
- By:
- Publication type:
- Article
Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2671, doi. 10.1111/liv.14990
- By:
- Publication type:
- Article
On‐treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B.
- Published in:
- Liver International, 2021, v. 41, n. 7, p. 1700, doi. 10.1111/liv.14934
- By:
- Publication type:
- Article
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1265, doi. 10.1111/liv.14849
- By:
- Publication type:
- Article
A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1997, doi. 10.1111/liv.13889
- By:
- Publication type:
- Article
Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens.
- Published in:
- Liver International, 2018, v. 38, n. 5, p. 821, doi. 10.1111/liv.13596
- By:
- Publication type:
- Article
Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long‐term nucleos(t)ide analogue therapy.
- Published in:
- Liver International, 2018, v. 38, n. 4, p. 627, doi. 10.1111/liv.13564
- By:
- Publication type:
- Article
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
- Published in:
- Liver International, 2016, v. 36, n. 12, p. 1755, doi. 10.1111/liv.13253
- By:
- Publication type:
- Article
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
- Published in:
- Liver International, 2016, v. 36, n. 10, p. 1433, doi. 10.1111/liv.13128
- By:
- Publication type:
- Article
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082
- By:
- Publication type:
- Article
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.
- Published in:
- Liver International, 2016, v. 36, n. 7, p. 954, doi. 10.1111/liv.13049
- By:
- Publication type:
- Article
Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.
- Published in:
- Liver International, 2012, v. 32, n. 6, p. 928, doi. 10.1111/j.1478-3231.2011.02742.x
- By:
- Publication type:
- Article
Genetic variation in NOS 2 A is associated with a sustained virological response to peginterferon plus ribavirin therapy for chronic hepatitis C in Taiwanese Chinese.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 7, p. 1206, doi. 10.1002/jmv.23598
- By:
- Publication type:
- Article
Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.
- Published in:
- Gerontology & Geriatric Medicine, 2019, v. 5, p. N.PAG, doi. 10.1177/2333721418817398
- By:
- Publication type:
- Article
Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.
- Published in:
- Gerontology & Geriatric Medicine, 2019, v. 5, p. N.PAG, doi. 10.1177/2333721418817398
- By:
- Publication type:
- Article